Building Evidence for Rare Paediatric Populations Through Model- Informed Extrapolation

• Addressing uncertainty and establishing confidence in extrapolation frameworks
• Lessons learned from regulatory interactions involving paediatric extrapolation strategies
• Opportunities to accelerate access to therapies for rare disease populations

Speakers: